Mercer Global Advisors
STOK icon

Mercer Global Advisors’s Stoke Therapeutics STOK Stock Holding History

Mercer Global Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.3K Buy
+1,538
New +$49.4K ﹤0.01% 4304

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mercer Global Advisors's STOK Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 1,538 shares worth $50.3K. The stake represents ﹤0.01% of the portfolio and ranks #4304 among its holdings.

179 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Mercer Global Advisors held 1,538 shares of Stoke Therapeutics worth $50.3K as of Q2 2026.
  • Stoke Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4304 holding.
  • 179 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.